Encompass Health Corp

EHC

$124.10

+0.01%

Encompass Health Corp

Encompass Health Corp is a Health Care company listed on NEW YORK STOCK EXCHANGE, INC..

Industry

Health Care

Exchange

NEW YORK STOCK EXCHANGE, INC.

Market Cap

$12.2B

P/E Ratio

—

Cash on Hand

Not available

Shares Outstanding

98.7M shares

Currency

USD

Visit website →

About

Encompass Health Corporation, formerly Amcare and HealthSouth, based in Birmingham, Alabama, is the United States's largest provider of inpatient rehabilitative services, offering facility-based care through its network of 173 inpatient rehabilitation hospitals located in 39 states and Puerto Rico. Encompass Health's hospitals focus on providing rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The company operated a home health and hospice business that was spun off as Enhabit in 2022.

via Wikipedia →

Earnings (EPS)

QuarterEPS EstimateEPS Actual

Q2 2026$1.49$1.55

Q1 2026$1.51$1.60

Q4 2025$1.31$1.46

Q3 2025$1.21$1.23

Loading Company intelligence…

Latest SEC Filings

Loading filings…

← Back to homepage

Loading… fetching the latest figures.

Encompass Health Corp

EHC

$124.10

+0.01%

Encompass Health Corp

Encompass Health Corp is a Health Care company listed on NEW YORK STOCK EXCHANGE, INC..

Industry

Health Care

Exchange

NEW YORK STOCK EXCHANGE, INC.

Market Cap

$12.2B

P/E Ratio

—

Cash on Hand

Not available

Shares Outstanding

98.7M shares

Currency

USD

Visit website →

About

via Wikipedia →

Earnings (EPS)

QuarterEPS EstimateEPS Actual

Q2 2026$1.49$1.55

Q1 2026$1.51$1.60

Q4 2025$1.31$1.46

Q3 2025$1.21$1.23

Company Intelligence

Annual figures from the company's own SEC filings. Tap any number to open the filing it came from.

Revenue

Growth = this year ÷ prior year − 1

Dec 2025: $5.9B+10.5%
Dec 2024: $5.4B+11.9%
Dec 2023: $4.8B+10.4%
Dec 2022: $4.3B+8.3%

Operating income

Margin = operating income ÷ revenue

Dec 2025: —
Dec 2024: —
Dec 2023: —
Dec 2022: $540M12.4% margin

Net income

Margin = net income ÷ revenue

Dec 2025: $566M9.5% margin
Dec 2024: $456M8.5% margin
Dec 2023: $352M7.3% margin
Dec 2022: $271M6.2% margin

Operating cash flow

Cash the business generated, vs net income above

Dec 2025: —
Dec 2024: —
Dec 2023: —
Dec 2022: $706M

Cash vs long-term debt

Cash − long-term debt. Excludes short-term borrowings and leases

Dec 2025: —
Dec 2024: —
Dec 2023: —
Dec 2022: —

Shares (weighted avg.)

Change = this year ÷ prior year − 1

Dec 2025: 101M+0.6%
Dec 2024: 100M+0.4%
Dec 2023: 100M+0.3%
Dec 2022: 99M+0.2%

Fiscal year ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022
RevenueGrowth = this year ÷ prior year − 1	$5.9B+10.5%	$5.4B+11.9%	$4.8B+10.4%	$4.3B+8.3%
Operating incomeMargin = operating income ÷ revenue	—	—	—	$540M12.4% margin
Net incomeMargin = net income ÷ revenue	$566M9.5% margin	$456M8.5% margin	$352M7.3% margin	$271M6.2% margin
Operating cash flowCash the business generated, vs net income above	—	—	—	$706M
Cash vs long-term debtCash − long-term debt. Excludes short-term borrowings and leases	—	—	—	—
Shares (weighted avg.)Change = this year ÷ prior year − 1	101M+0.6%	100M+0.4%	100M+0.3%	99M+0.2%

What the numbers show

Revenue rose in each of the last 4 fiscal years shown.
Weighted average shares increased 1.3% between Dec 2022 and Dec 2025.

Worth a closer look

Automatic checks on the figures above. A flag is a pattern to investigate, not a finding of wrongdoing, and each one lists ordinary explanations for it.

None of the 2checks we could run on this company's figures were triggered.

See every flagged company in Market Watch →

Rules checked

Revenue up, operating cash flow down — not run. Not enough comparable annual figures reported to run this check.
Profit not matched by cash — not run. Not enough comparable annual figures reported to run this check.
Receivables growing faster than revenue — not triggered. Trade receivables up 15% or more in the latest year and at least 15 percentage points ahead of revenue growth.
Share count rising — not triggered. Weighted average shares up 5% or more in a year, or 10% or more over three years.
Operating margin shrinking — not run. Not enough comparable annual figures reported to run this check.

Source: SEC EDGAR annual reports (Form 10-K), latest filed 2026-02-26. If a company later restates a year, the most recent filing is used. Dashes mean the company did not report that line in a form we could read. For information only, not investment advice.

Loading Company intelligence…

Latest SEC Filings

Loading filings…

← Back to homepage

Company Intelligence

Annual figures from the company's own SEC filings. Tap any number to open the filing it came from.

Revenue

Growth = this year ÷ prior year − 1

Dec 2025: $5.9B+10.5%
Dec 2024: $5.4B+11.9%
Dec 2023: $4.8B+10.4%
Dec 2022: $4.3B+8.3%

Operating income

Margin = operating income ÷ revenue

Dec 2025: —
Dec 2024: —
Dec 2023: —
Dec 2022: $540M12.4% margin

Net income

Margin = net income ÷ revenue

Dec 2025: $566M9.5% margin
Dec 2024: $456M8.5% margin
Dec 2023: $352M7.3% margin
Dec 2022: $271M6.2% margin

Operating cash flow

Cash the business generated, vs net income above

Dec 2025: —
Dec 2024: —
Dec 2023: —
Dec 2022: $706M

Cash vs long-term debt

Cash − long-term debt. Excludes short-term borrowings and leases

Dec 2025: —
Dec 2024: —
Dec 2023: —
Dec 2022: —

Shares (weighted avg.)

Change = this year ÷ prior year − 1

Dec 2025: 101M+0.6%
Dec 2024: 100M+0.4%
Dec 2023: 100M+0.3%
Dec 2022: 99M+0.2%

Fiscal year ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022
RevenueGrowth = this year ÷ prior year − 1	$5.9B+10.5%	$5.4B+11.9%	$4.8B+10.4%	$4.3B+8.3%
Operating incomeMargin = operating income ÷ revenue	—	—	—	$540M12.4% margin
Net incomeMargin = net income ÷ revenue	$566M9.5% margin	$456M8.5% margin	$352M7.3% margin	$271M6.2% margin
Operating cash flowCash the business generated, vs net income above	—	—	—	$706M
Cash vs long-term debtCash − long-term debt. Excludes short-term borrowings and leases	—	—	—	—
Shares (weighted avg.)Change = this year ÷ prior year − 1	101M+0.6%	100M+0.4%	100M+0.3%	99M+0.2%

What the numbers show

Revenue rose in each of the last 4 fiscal years shown.
Weighted average shares increased 1.3% between Dec 2022 and Dec 2025.

Worth a closer look

Automatic checks on the figures above. A flag is a pattern to investigate, not a finding of wrongdoing, and each one lists ordinary explanations for it.

None of the 2checks we could run on this company's figures were triggered.

See every flagged company in Market Watch →

Rules checked

Revenue up, operating cash flow down — not run. Not enough comparable annual figures reported to run this check.
Profit not matched by cash — not run. Not enough comparable annual figures reported to run this check.
Receivables growing faster than revenue — not triggered. Trade receivables up 15% or more in the latest year and at least 15 percentage points ahead of revenue growth.
Share count rising — not triggered. Weighted average shares up 5% or more in a year, or 10% or more over three years.
Operating margin shrinking — not run. Not enough comparable annual figures reported to run this check.